Page last updated: 2024-10-29

avapro and Cryptogenic Fibrosing Alveolitis

avapro has been researched along with Cryptogenic Fibrosing Alveolitis in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Research Excerpts

ExcerptRelevanceReference
"Idiopathic pulmonary fibrosis is a specific form of chronic fibrosing interstitial pneumonia that is limited to the lung."1.39Preventive effect of irbesartan on bleomycin-induced lung injury in mice. ( Asakawa, K; Moriyama, H; Narita, I; Sakagami, T; Suzuki, E; Tajima, S; Takada, T; Tanaka, J, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tanaka, J1
Tajima, S1
Asakawa, K1
Sakagami, T1
Moriyama, H1
Takada, T1
Suzuki, E1
Narita, I1

Other Studies

1 other study available for avapro and Cryptogenic Fibrosing Alveolitis

ArticleYear
Preventive effect of irbesartan on bleomycin-induced lung injury in mice.
    Respiratory investigation, 2013, Volume: 51, Issue:2

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antibiotics, Antineoplastic; Biphenyl Compounds; B

2013